PWPhonphimon Wongthida

Phonphimon Wongthida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Phonphimon Wongthida has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Jaraspim Narkpuk

    Virology and Cell Technology Laboratory, National Center for Genetic Engineering and Biotechnology (BIOTEC), 113 Thailand Science Park, Phahonyothin Rd., Klong Nueng, Klong Luang, Pathum Thani, 12120, Thailand

    2 shared publications
  • Anan Jongkaewwattana

    Virology and Cell Technology Laboratory, National Center for Genetic Engineering and Biotechnology (BIOTEC), 113 Thailand Science Park, Phahonyothin Rd., Klong Nueng, Klong Luang, Pathum Thani, 12120, Thailand

    1 shared publication
  • Anan Jongkaewwattana

    Virology and Vaccine Technology Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand

    1 shared publication
  • Asawin Wanitchang

    Virology and Cell Technology Laboratory, National Center for Genetic Engineering and Biotechnology (BIOTEC), 113 Thailand Science Park, Phahonyothin Rd., Klong Nueng, Klong Luang, Pathum Thani, 12120, Thailand

    1 shared publication
  • Fatima Carla T. Bertulfo

    Department of Molecular Biology and Biotechnology, University of the Phillipines Los Banos, Laguna, Phillipines

    1 shared publication
  • Juggragarn Jengarn

    Virology and Cell Technology Laboratory, National Center for Genetic Engineering and Biotechnology (BIOTEC), 113 Thailand Science Park, Phahonyothin Rd., Klong Nueng, Klong Luang, Pathum Thani, 12120, Thailand

    1 shared publication

Latest Publications

  • Open Access

    In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion

    by Phonphimon Wongthida, Juggragarn Jengarn, Jaraspim Narkpuk, Pongpisid Koonyosying, Kanjana Srisutthisamphan, Asawin Wanitchang, Pornsawan Leaungwutiwong, Samaporn Teeravechyan, Anan Jongkaewwattana

    Vesicular stomatitis virus (VSV) is highly immunogenic and able to stimulate both innate and adaptive immune responses. However, its ability to induce adverse effects has held back the use of VSV as a potential vaccine vector. In this study we developed VSV-ΔP, a safe yet potent replication-defective recombinant VSV in which the phosphoprotein (P) gene was deleted. VSV-ΔP replicated only in supporting cells expressing P (BHK-P cells) and at levels more than 2 logs lower than VSV. In vivo studies indicated that the moderate replication of VSV-ΔP in vitro was associated with the attenuation of this virus in the mouse model, whereas mice intracranially injected with VSV succumbed to neurotoxicity. Furthermore, we constructed VSV and VSV-ΔP expressing a variety of antigens including hemagglutinin-neuraminidase (HN) from Newcastle disease virus (NDV), hemagglutinin (HA) from either a 2009 H1N1 pandemic influenza virus (pdm/09) or the avian H7N9. VSV and VSV-ΔP incorporated the foreign antigens on their surface resulting in induction of robust neutralizing antibody, serum IgG, and hemagglutination inhibition (HAI) titers against their corresponding viruses. These results indicated that VSV with P gene deletion was attenuated in vitro and in vivo, and possibly expressed the foreign antigen on its surface. Therefore, the P gene-deletion strategy may offer a potentially useful and safer approach for attenuating negative-sense RNA viruses which use phosphoprotein as a cofactor for viral replication.


  • Mechanistic study of intertypic nucleoprotein complex formation and its inhibitory effect toward influenza A virus

    by Jaraspim Narkpuk, Peera Jaru-Ampornpan, Theressa Subali, Fatima Carla T. Bertulfo, Phonphimon Wongthida, Anan Jongkaewwattana